ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 60 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,991 | +200.1% | 20,385 | -23.3% | 0.00% | – |
| Q2 2023 | $8,661 | -33.5% | 26,568 | -12.3% | 0.00% | – |
| Q1 2023 | $13,023 | -41.5% | 30,286 | -27.9% | 0.00% | – |
| Q4 2022 | $22,271 | +11.4% | 42,020 | +56.3% | 0.00% | – |
| Q3 2022 | $20,000 | -28.6% | 26,890 | +8.0% | 0.00% | – |
| Q2 2022 | $28,000 | -50.0% | 24,902 | -9.8% | 0.00% | – |
| Q1 2022 | $56,000 | +75.0% | 27,621 | +145.2% | 0.00% | – |
| Q4 2021 | $32,000 | +28.0% | 11,264 | +95.2% | 0.00% | – |
| Q3 2021 | $25,000 | -63.2% | 5,770 | -55.0% | 0.00% | – |
| Q2 2021 | $68,000 | +223.8% | 12,822 | +184.7% | 0.00% | – |
| Q1 2021 | $21,000 | -8.7% | 4,503 | -37.7% | 0.00% | – |
| Q4 2020 | $23,000 | +15.0% | 7,229 | +25.8% | 0.00% | – |
| Q3 2020 | $20,000 | +300.0% | 5,746 | +366.8% | 0.00% | – |
| Q2 2020 | $5,000 | -92.8% | 1,231 | -93.2% | 0.00% | – |
| Q1 2020 | $69,000 | -69.6% | 18,080 | -51.9% | 0.00% | – |
| Q4 2019 | $227,000 | -14.0% | 37,595 | +7.6% | 0.00% | – |
| Q3 2019 | $264,000 | -75.0% | 34,953 | -55.1% | 0.00% | – |
| Q2 2019 | $1,055,000 | +2411.9% | 77,845 | +907.8% | 0.00% | – |
| Q1 2019 | $42,000 | +10.5% | 7,724 | -38.6% | 0.00% | – |
| Q4 2018 | $38,000 | -17.4% | 12,571 | +125.2% | 0.00% | – |
| Q3 2018 | $46,000 | -8.0% | 5,581 | +7.2% | 0.00% | – |
| Q2 2018 | $50,000 | -21.9% | 5,208 | -29.9% | 0.00% | – |
| Q1 2018 | $64,000 | -34.0% | 7,433 | -4.0% | 0.00% | – |
| Q4 2017 | $97,000 | +12.8% | 7,742 | -24.4% | 0.00% | – |
| Q3 2017 | $86,000 | -64.8% | 10,235 | -28.7% | 0.00% | – |
| Q2 2017 | $244,000 | +212.8% | 14,354 | +268.3% | 0.00% | – |
| Q1 2017 | $78,000 | +4.0% | 3,897 | -19.3% | 0.00% | – |
| Q4 2016 | $75,000 | +476.9% | 4,829 | +382.9% | 0.00% | – |
| Q3 2016 | $13,000 | -69.8% | 1,000 | -76.8% | 0.00% | – |
| Q4 2015 | $43,000 | +59.3% | 4,311 | +135.7% | 0.00% | – |
| Q3 2015 | $27,000 | – | 1,829 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ETF MANAGERS GROUP, LLC | 3,662,342 | $7,874,000 | 0.16% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 213,469 | $438,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 150,914 | $309,000 | 0.04% |
| Bernardo Wealth Planning LLC | 30,469 | $62,000 | 0.03% |
| Penserra Capital Management LLC | 351,154 | $719,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 175,900 | $361,000 | 0.01% |
| Founders Capital Management | 3,000 | $9,000 | 0.01% |
| King Wealth Management Group | 16,000 | $33,000 | 0.01% |
| Aquatic Capital Management LLC | 1,900 | $4,000 | 0.01% |
| Newbridge Financial Services Group, Inc. | 6,075 | $12,000 | 0.01% |